The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells

被引:70
作者
Chu, VC [1 ]
McElroy, LJ [1 ]
Chu, V [1 ]
Bauman, BE [1 ]
Whittaker, GR [1 ]
机构
[1] Cornell Univ, Dept Microbiol & Immunol, Ctr Vet Med, Ithaca, NY 14853 USA
关键词
D O I
10.1128/JVI.80.7.3180-3188.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronaviruses are the causative agents of respiratory disease in humans and animals, including severe acute respiratory syndrome. Fusion of coronaviruses is generally thought to occur at neutral pH, although there is also evidence for a role of acidic endosomes during entry of a variety of coronaviruses. Therefore, the molecular basis of coronavirus fusion during entry into host cells remains incompletely defined. Here, we examined coronavirus-cell fusion and entry employing the avian coronavirus infectious bronchitis virus (IBV). Virus entry into cells was inhibited by acidotropic bases and by other inhibitors of pH-dependent endocytosis. We carried out fluorescence-dequenching fusion assays of R18-labeled virions and show that for IBV, coronavirus-cell fusion occurs in a low-pH-dependent manner, with a half-maximal rate of fusion occurring at pH 5.5. Fusion was reduced, but still occurred, at lower temperatures (20 degrees C). We observed no effect of inhibitors of endosomal proteases on the fusion event. These data are the first direct measure of virus-cell fusion for any coronavirus and demonstrate that the coronavirus IBV employs a direct, low-pH-dependent virus-cell fusion activation reaction. We further show that IBV was not inactivated, and fusion was unaffected, by prior exposure to pH 5.0 buffer. Virions also showed evidence of reversible conformational changes in their surface proteins, indicating that aspects of the fusion reaction may be reversible in nature.
引用
收藏
页码:3180 / 3188
页数:9
相关论文
共 57 条
  • [1] BEAUDETTE F. R., 1937, Journal of the American Veterinary Medical Association, V90, P51
  • [2] Severe acute respiratory syndrome coroavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
    Bosch, BJ
    Martina, BEE
    van der Zee, R
    Lepault, J
    Haijema, BJ
    Versluis, C
    Heck, AJR
    de Groot, R
    Osterhaus, ADME
    Rottier, PJM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (22) : 8455 - 8460
  • [3] The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex
    Bosch, BJ
    van der Zee, R
    de Haan, CAM
    Rottier, PJM
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (16) : 8801 - 8811
  • [4] THE INFLUENZA HEMAGGLUTININ PRECURSOR AS AN ACID-SENSITIVE PROBE OF THE BIOSYNTHETIC-PATHWAY
    BOULAY, F
    DOMS, RW
    WILSON, I
    HELENIUS, A
    [J]. EMBO JOURNAL, 1987, 6 (09) : 2643 - 2650
  • [5] CORONAVIRUS IBV - REMOVAL OF SPIKE GLYCOPOLYPEPTIDE-S1 BY UREA ABOLISHES INFECTIVITY AND HEMAGGLUTINATION BUT NOT ATTACHMENT TO CELLS
    CAVANAGH, D
    DAVIS, PJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1986, 67 : 1443 - 1448
  • [6] Cavanagh D, 2005, BIRK ADV INFECT DIS, P1
  • [7] Cavanagh D., 2003, DIS POULTRY, V11th, P101
  • [8] Cavanagh D., 1995, CORONAVIRIDAE, P73, DOI DOI 10.1007/978-1-4899-1531-3_5
  • [9] HEPTAD REPEAT SEQUENCES ARE LOCATED ADJACENT TO HYDROPHOBIC REGIONS IN SEVERAL TYPES OF VIRUS FUSION GLYCOPROTEINS
    CHAMBERS, P
    PRINGLE, CR
    EASTON, AJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1990, 71 : 3075 - 3080
  • [10] HIV entry and its inhibition
    Chan, DC
    Kim, PS
    [J]. CELL, 1998, 93 (05) : 681 - 684